SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
JBS S.A. (JBSAY) trades at a trailing P/E of 8.6, forward P/E of 1.7. Trailing earnings yield is 11.59%, forward earnings yield 60.24%. PEG 0.06 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (8.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.06); earnings yield beats bond yields (11.59%).
- Forward P/E 1.7 (down from trailing 8.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.06 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 11.59% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 60.24% as earnings recover.
Overall SharesGrow Score: 62/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — JBSAY
Valuation Multiples
P/E (TTM)8.6
Forward P/E1.7
PEG Ratio0.06
Forward PEG0.06
P/B Ratio0.00
P/S Ratio0.20
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.60
Forward EPS (Est.)$8.31
Book Value / Share$0.00
Revenue / Share$69.59
FCF / Share$0.00
Yields & Fair Value
Earnings Yield11.59%
Forward Earnings Yield60.24%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$3.20 |
$162.91B |
$4.64B |
2.8% |
| 2016 |
$0.18 |
$170.38B |
$375.97M |
0.2% |
| 2017 |
$0.38 |
$163.17B |
$534.2M |
0.3% |
| 2018 |
$0.02 |
$181.68B |
$25.2M |
0% |
| 2019 |
$4.56 |
$204.52B |
$6.07B |
3% |
| 2020 |
$3.46 |
$270.2B |
$4.6B |
1.7% |
| 2021 |
$16.52 |
$350.7B |
$21.24B |
6.1% |
| 2022 |
$13.86 |
$374.85B |
$15.85B |
4.2% |
| 2023 |
$-0.96 |
$363.82B |
$-1.06B |
-0.3% |
| 2024 |
$1.60 |
$77.18B |
$1.77B |
2.3% |
